Unknown

Dataset Information

Drug-drug interaction perpetrators of oxycodone in patients with cancer: frequency and clinical relevance.


ABSTRACT:

Aim

Oxycodone is known to have numerous drug-drug interactions (DDIs) that can potentially decrease efficacy or lead to adverse drug reactions (ADRs). However, there is limited research on the frequency of DDIs associated with oxycodone, which is important in optimising pharmacovigilance and the need for additional research on certain DDIs. In this study, the frequency of pharmacologically and clinically relevant DDI perpetrators was studied in patients with cancer.

Methods

This was a cross-sectional study using hospital pharmacy records of patients with cancer who were prescribed oxycodone between September 2021 and September 2022. Medication records of patients prescribed oxycodone during a period of ≥ 5 consecutive days (= oxycodone treatment episodes) were reviewed to id

SUBMITTER: Hulskotte LMG 

PROVIDER: S-EPMC10873430 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature